Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

July 31, 2006

Conditions
Bipolar Disorder
Interventions
DRUG

quetiapine fumarate

Trial Locations (32)

Unknown

Research Site, Scottsdale

Research Site, Riverside

Research Site, Sacramento

Research Site, San Diego

Research Site, Denver

Research Site, Alamonte

Research Site, Jacksonville

Research Site, Miami

Research Site, Augusta

Research Site, Chicago

Research Site, Wichita

Research Site, New Orleans

Research Site, Saint Charles

Research Site, Las Vegas

Research Site, Clementon

Research Site, Piscataway

Research Site, Rochester

Research Site, Chapel Hill

Research Site, Cincinnati

Research Site, Cleveland

Research Site, Lyndhurst

Research Site, Oklahoma City

Research Site, Philadelphia

Research Site, Madison

Research Site, Austin

Research Site, Houston

Research Site, San Antonio

Research Site, Richmond

Research Site, Virginia Beach

Research Site, Bellevue

Research Site, Kirkland

Research Site, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00090311 - Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania | Biotech Hunter | Biotech Hunter